Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation develops and sells cannabis products for adult-use and medical markets, with common shares trading as CGC on Nasdaq and WEED on the TSX. Company updates frequently cover Canadian brand activity across Tweed, Deelish, 7ACRES, DOJA, Deep Space and related formats including flower, pre-rolls, vapes, softgels and minor cannabinoid products.
News also centers on medical cannabis services through Canada House Clinics and the Abba Medix online channel, Storz & Bickel vaporization devices, operating and financial results, capital-structure actions, shareholder voting matters and governance changes. Canopy Growth also discloses its unconsolidated, non-controlling interest in Canopy USA as exposure to the U.S. THC market.
Canopy Growth Corporation (NASDAQ: CGC) released its inaugural Environmental, Social, and Governance (ESG) Report for 2020, highlighting its commitment to sustainable practices. The report includes a baseline assessment of energy use and greenhouse gas emissions, a $1 million investment in drug war impact initiatives, and the registration of 23,000 patients in its Compassionate Pricing Program. Canopy Growth has taken significant steps towards diversity and inclusion, achieving near gender parity and establishing Employee Resource Groups. The company aims to lead the cannabis industry responsibly and sustainably.
Canopy Growth Corporation has agreed to divest its subsidiary, C³ Cannabinoid Compound Company GmbH, to Dermapharm Holding SE for an upfront payment of EUR80M (approx. CAD$115.5M) and potential earnout payments up to EUR42.6M (approx. CAD$61.4M). This strategic sale allows Canopy Growth to focus on its core consumer packaged goods model, reducing operational complexities and capital investment requirements by over CAD$50M. The transaction is expected to close by January 31, 2022, with all C³ employees remaining with Dermapharm.
Beatrice Society has announced the formation of its Board of Directors, appointing Gary Yeoman as Chairman. The board includes seasoned professionals Lorne Gertner and Krisztián Tóth. Yeoman, previously at Voxtur Analytics and Altus Group, aims to build on recent acquisitions in psychedelics and wellness. Gertner co-founded Cannasat Therapeutics and has notable ties to the cannabis industry, while Tóth specializes in corporate finance. The board's expertise is expected to strengthen Beatrice's position in the growing psychedelic therapy market.
On November 19, 2021, Canopy Growth announced critical changes in its Executive Management Committee. Mike Lee, Chief Financial Officer, and Rade Kovacevic, Chief Product Officer, will depart by December 31, 2021. Judy Hong and Tara Rozalowsky have been appointed as interim CFO and Chief Product Officer, respectively. CEO David Klein emphasized that these changes aim to enhance the company’s long-term growth and shareholder value. Canopy Growth continues to pursue its strategic priorities while maintaining its leadership position in the cannabis industry.
Canopy Growth Corporation (CGC) reported financial results for Q2 FY2022, ending September 30, 2021. Net revenue was $131.4 million, a 3% decline from Q2 FY2021, with cannabis revenue rising 1% to $95 million. The company announced plans to acquire Wana Brands, enhancing its U.S. presence. Gross margin dropped to -54%, impacted by inventory write-downs of $87 million, while adjusted EBITDA loss widened to $163 million. Despite challenges, Canopy remains optimistic about U.S. growth, aiming to stabilize Canadian operations and enhance product distribution.
On October 28, 2021, Martha Stewart CBD announced the release of new CBD products, including the permanent Harvest Medley CBD Wellness Gummies and limited-edition Mini CBD Peppermint Ribbons and Snowflake CBD Gummy Sampler for the holiday season. The brand has exceeded initial projections and is the fastest-growing CBD brand, with a 20% quarter-over-quarter growth. The Harvest Medley Gummies feature popular flavors like Green Apple, Concord Grape, and Pomegranate. These products aim to enhance wellness while celebrating Martha Stewart's commitment to making CBD accessible.
Canopy Growth Corporation (CGC) will announce its financial results for the second quarter of fiscal year 2022, ending September 30, 2021, on November 5, 2021, before market open. The company's executive team, including CEO David Klein and CFO Mike Lee, will host an audio webcast at 10:00 AM ET on the same day to discuss the results. Canopy Growth, a leading cannabis company, continues to expand its portfolio and market presence, including partnerships with major brands and growth in health and wellness sectors.
Canopy Growth Corporation has announced its agreement to acquire Wana Brands, the leading cannabis edibles brand in North America, upon federal legalization of THC in the U.S. This strategic move, valued at USD 297.5 million, aims to enhance Canopy's presence in the U.S. cannabis market, which is expected to expand significantly. Wana operates in 12 U.S. states and has plans to reach more than 20 states by the end of 2022. The acquisition is seen as a pivotal step in Canopy's growth strategy, leveraging Wana's established brand and profitable business model.
Karma Water has launched its first CBD beverage, Karma CBD Water, in collaboration with Canopy Growth Corporation. This innovative drink combines 25mg of CBD distillate made from U.S. hemp with Karma's patented Push Cap technology, designed to preserve potency until consumption. Available in five natural flavors, the product aims to cater to the growing demand for quick-acting wellness beverages. Distributed through Constellation Brands' beer network, Karma CBD Water is positioned to strengthen both companies' market presence in the CBD category.
On September 14, 2021, Canopy Growth Corporation (NASDAQ: CGC) held its annual general and special meeting where 66.01% of issued shares were voted. All proposals in the proxy statement were approved by the majority. Key results included the election of directors with high support, such as Judy A. Schmeling with 98.59% votes in favor, and the appointment of KPMG LLP as auditors for fiscal year 2022. The shareholders also approved amendments to the Company’s By-laws and an advisory resolution on executive compensation.